Torthaí cuardaigh - Dijkmans, B A C

High levels of human anti‐human antibodies to adalimumab in a patient not responding to adalimumab treatment de réir Bartelds, G M, Wolbink, G J, Stapel, S, Aarden, L, Lems, W F, Dijkmans, B A C, Nurmohamed, M T

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implic... de réir van Kuijk, A W R, Reinders‐Blankert, P, Smeets, T J M, Dijkmans, B A C, Tak, P P

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma de réir Swaneveld, F. H., van Vugt, R. M., de Boer, J. P., Dijkmans, B. A. C., Lems, W. F.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis de réir van Halm, V P, Slot, M C, Nurmohamed, M T, Tervaert, J W Cohen, Dijkmans, B A C, Voskuyl, A E

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases de réir Burmester, G R, Mease, P, Dijkmans, B A C, Gordon, K, Lovell, D, Panaccione, R, Perez, J, Pangan, A L

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

2-Deoxy-2-[F-18]fluoro-D-glucose Joint Uptake on Positron Emission Tomography Images: Rheumatoid Arthritis Versus Osteoarthritis de réir Elzinga, E. H., van der Laken, C. J., Comans, E. F. I., Lammertsma, A. A., Dijkmans, B. A. C., Voskuyl, A. E.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review de réir van der Weijden, M. A. C., Claushuis, T. A. M., Nazari, T., Lems, W. F., Dijkmans, B. A. C., van der Horst-Bruinsma, I. E.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Statin therapy might be beneficial for patients with ankylosing spondylitis de réir van Denderen, J C, Peters, M J L, van Halm, V P, van der Horst‐Bruinsma, I E, Dijkmans, B A C, Nurmohamed, M T

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Cervical spine involvement is rare in early arthritis de réir van Eijk, I C, Nielen, M M J, van Soesbergen, R M, Hamburger, H L, Kerstens, P J S M, Dijkmans, B A C, van Schaardenburg, D

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation de réir de Vries, M K, Wolbink, G J, Stapel, S O, de Groot, E R, Dijkmans, B A C, Aarden, L A, van der Horst‐Bruinsma, I E

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies de réir van der Weijden, M. A. C., van Denderen, J. C., Lems, W. F., Heymans, M. W., Dijkmans, B. A. C., van der Horst-Bruinsma, I. E.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial de réir van der Heijde, D, Schiff, M H, Sieper, J, Kivitz, A J, Wong, R L, Kupper, H, Dijkmans, B A C, Mease, P J, Davis, J C

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheuma... de réir Vis, M, Havaardsholm, E A, Haugeberg, G, Uhlig, T, Voskuyl, A E, van de Stadt, R J, Dijkmans, B A C, Woolf, A D, Kvien, T K, Lems, W F

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti‐infliximab in responders and non‐responders to therapy for rheumatoid arthritis de réir van der Laken, C J, Voskuyl, A E, Roos, J C, van Walsum, M Stigter, de Groot, E R, Wolbink, G, Dijkmans, B A C, Aarden, L A

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tiss... de réir van Kuijk, A W R, Gerlag, D M, Vos, K, Wolbink, G, de Groot, M, de Rie, M A, Zwinderman, A H, Dijkmans, B A C, Tak, P P

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage de réir de Vries‐Bouwstra, J K, Goekoop‐Ruiterman, Y P M, Wesoly, J, Hulsmans, H J, de Craen, A J M, Breedveld, F C, Dijkmans, B A C, Allaart, C F, Huizinga, T W J

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium de réir Wijbrandts, C A, Dijkgraaf, M G W, Kraan, M C, Vinkenoog, M, Smeets, T J, Dinant, H, Vos, K, Lems, W F, Wolbink, G J, Sijpkens, D, Dijkmans, B A C, Tak, P P

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients de réir van der Pouw Kraan, T C T M, Wijbrandts, C A, van Baarsen, L G M, Voskuyl, A E, Rustenburg, F, Baggen, J M, Ibrahim, S M, Fero, M, Dijkmans, B A C, Tak, P P, Verweij, C L

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis de réir Nielen, M M J, van Schaardenburg, D, Reesink, H W, Twisk, J W R, van de Stadt, R J, van der Horst‐Bruinsma, I E, de Koning, M H M T, Habibuw, M R, Dijkmans, B A C

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis de réir Peters, M J L, Vis, M, van Halm, V P, Wolbink, G J, Voskuyl, A E, Lems, W F, Dijkmans, B A C, Twisk, J W R, de Koning, M H M T, van de Stadt, R J, Nurmohamed, M T

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán